Our Mission We are developing innovative drugs to target challenging protein-protein interactions in cancer, leveraging our proprietary phenotypic drug discovery platform. Having successfully completed hit validation for our first program, we are now seeking seed investors to advance to the lead identification stage. Read more about our science and about our company. Seed Round Open…